These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Symptoms and signs of primary melanoma: important indicators of Breslow depth. Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355 [TBL] [Abstract][Full Text] [Related]
47. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases. Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838 [TBL] [Abstract][Full Text] [Related]
48. Malignant melanoma in Turkey: a single institution's experience on 475 cases. Tas F; Kurul S; Camlica H; Topuz E Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409 [TBL] [Abstract][Full Text] [Related]
49. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry. Eigentler TK; Buettner PG; Leiter U; Garbe C; J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379 [TBL] [Abstract][Full Text] [Related]
50. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. Fisher NM; Schaffer JV; Berwick M; Bolognia JL J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344 [TBL] [Abstract][Full Text] [Related]
51. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas. Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942 [TBL] [Abstract][Full Text] [Related]
52. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282 [TBL] [Abstract][Full Text] [Related]
53. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
54. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? Dal H; Boldemann C; Lindelöf B Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388 [TBL] [Abstract][Full Text] [Related]
55. Melanomas in renal transplant recipients. Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778 [TBL] [Abstract][Full Text] [Related]
58. Epidemiology and clinical and pathologic characteristics of cutaneous malignant melanoma in Abruzzo (Italy). Amerio P; Manzoli L; Auriemma M; Carbone A; Proietto G; Angelucci D; Tulli A Int J Dermatol; 2009 Jul; 48(7):718-22. PubMed ID: 19570077 [TBL] [Abstract][Full Text] [Related]
59. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Montella A; Gavin A; Middleton R; Autier P; Boniol M Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307 [TBL] [Abstract][Full Text] [Related]
60. [Melanomas more serious in the elderly]. van der Meijden WA; van Bruchem-Visser RL; Thio HB; van der Cammen TJ Ned Tijdschr Geneeskd; 2010; 154():A1535. PubMed ID: 20482904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]